Cargando…
Delayed immune-related sclerosing cholangitis after discontinuation of pembrolizumab: A case report
BACKGROUND: Secondary sclerosing cholangitis, characterized by biliary obstruction, can be caused by drugs such as immune checkpoint inhibitors (ICIs). While there a few reports of sclerosing cholangitis after immune checkpoint inhibitor administration, no case has been reported after discontinuatio...
Autores principales: | Tanaka, Takeshi, Sakai, Arata, Tsujimae, Masahiro, Yamada, Yasutaka, Kobayashi, Takashi, Masuda, Atsuhiro, Kodama, Yuzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372812/ https://www.ncbi.nlm.nih.gov/pubmed/36161046 http://dx.doi.org/10.3748/wjg.v28.i28.3732 |
Ejemplares similares
-
Eosinophilic Cholangitis Without Biliary Stricture After the Treatment of Eosinophilic Esophagitis
por: Tanaka, Shunta, et al.
Publicado: (2019) -
Use of Peroral Pancreatoscopy in the Diagnosis of Elusive Intraductal Papillary Mucinous Neoplasm With High-Grade Dysplasia
por: Sarita, Mabel Angela T., et al.
Publicado: (2023) -
Clinical management for malignant afferent loop obstruction
por: Sakai, Arata, et al.
Publicado: (2021) -
Progression of Recurrent Pancreatitis to Chronic Pancreatitis within 3 Years due to SPINK1 Mutation IVS3+2T>C
por: Horitani, Susumu, et al.
Publicado: (2023) -
Clinical outcomes of ampullary neoplasms in resected margin positive or uncertain cases after endoscopic papillectomy
por: Sakai, Arata, et al.
Publicado: (2019)